Market Closed -
Australian S.E.
02:10:05 2023-04-03 am EDT
|
5-day change
|
1st Jan Change
|
0.41
AUD
|
-2.38%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
195.7
|
191.1
|
100.4
|
156.5
|
143.7
|
151
|
Enterprise Value (EV)
1 |
186.1
|
157.3
|
90.66
|
133.7
|
128.8
|
-42.09
|
P/E ratio
|
-27.8
x
|
-51.6
x
|
-12.2
x
|
-14.8
x
|
-31.1
x
|
1.13
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
88,117,926,694
x
|
854,497,966
x
|
-
|
-
|
1,721,129,674
x
|
EV / Revenue
|
-
|
72,534,660,673
x
|
771,614,613
x
|
-
|
-
|
-479,723,157
x
|
EV / EBITDA
|
-65.6
x
|
-44.8
x
|
-23.9
x
|
-28.1
x
|
-28.9
x
|
10
x
|
EV / FCF
|
-73
x
|
16.3
x
|
-6.98
x
|
-159
x
|
-43.8
x
|
8.13
x
|
FCF Yield
|
-1.37%
|
6.15%
|
-14.3%
|
-0.63%
|
-2.29%
|
12.3%
|
Price to Book
|
5.09
x
|
2.91
x
|
1.79
x
|
2.33
x
|
2.25
x
|
0.78
x
|
Nbr of stocks (in thousands)
|
264,422
|
318,546
|
318,741
|
368,334
|
368,334
|
368,334
|
Reference price
2 |
0.7400
|
0.6000
|
0.3150
|
0.4250
|
0.3900
|
0.4100
|
Announcement Date
|
3/20/19
|
3/31/20
|
3/31/21
|
3/29/22
|
3/29/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.002169
|
0.1175
|
-
|
-
|
0.0877
|
EBITDA
1 |
-2.839
|
-3.508
|
-3.796
|
-4.763
|
-4.458
|
-4.2
|
EBIT
1 |
-2.847
|
-3.514
|
-3.8
|
-4.769
|
-4.466
|
-4.205
|
Operating Margin
|
-
|
-162,010.56%
|
-3,233.77%
|
-
|
-
|
-4,792.66%
|
Earnings before Tax (EBT)
1 |
-6.944
|
-3.149
|
-8.259
|
-10.04
|
-4.617
|
1.515
|
Net income
1 |
-6.944
|
-3.149
|
-8.259
|
-10.04
|
-4.617
|
133.8
|
Net margin
|
-
|
-145,169.85%
|
-7,029.25%
|
-
|
-
|
152,476.13%
|
EPS
2 |
-0.0266
|
-0.0116
|
-0.0259
|
-0.0287
|
-0.0125
|
0.3632
|
Free Cash Flow
1 |
-2.551
|
9.679
|
-13
|
-0.8412
|
-2.943
|
-5.181
|
FCF margin
|
-
|
446,257.95%
|
-11,060.35%
|
-
|
-
|
-5,904.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/20/19
|
3/31/20
|
3/31/21
|
3/29/22
|
3/29/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
9.55
|
33.8
|
9.74
|
22.9
|
14.9
|
193
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2.55
|
9.68
|
-13
|
-0.84
|
-2.94
|
-5.18
|
ROE (net income / shareholders' equity)
|
-17.6%
|
-6.05%
|
-13.6%
|
-16.3%
|
-7.04%
|
1.17%
|
ROA (Net income/ Total Assets)
|
-4.41%
|
-3.77%
|
-3.53%
|
-4.75%
|
-4.18%
|
-2.02%
|
Assets
1 |
157.3
|
83.41
|
233.9
|
211.4
|
110.4
|
-6,628
|
Book Value Per Share
2 |
0.1500
|
0.2100
|
0.1800
|
0.1800
|
0.1700
|
0.5300
|
Cash Flow per Share
2 |
0.0400
|
0.1100
|
0.0300
|
0.0600
|
0.0400
|
0.5200
|
Capex
1 |
0.02
|
-
|
0.01
|
0.02
|
0
|
-
|
Capex / Sales
|
-
|
-
|
4.97%
|
-
|
-
|
-
|
Announcement Date
|
3/20/19
|
3/31/20
|
3/31/21
|
3/29/22
|
3/29/23
|
3/27/24
|
Last Close Price
0.41
AUD Average target price
0.85
AUD Spread / Average Target +107.32% Consensus |
1st Jan change
|
Capi.
|
---|
| -.--% | 98.49M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B | | +3.85% | 8.11B |
Diversified Chemicals
|